Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 55, Issue 8, 2010, Pages 2327-2331

  Koutroubakis, Ioannis E ^a   Oustamanolakis, Pantelis ^a   Karakoidas, Christos ^b   Mantzaris, Gerassimos J ^b   Kouroumalis, Elias A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Anemia; Crohn's disease; Infusions; Iron deficiency anemia; Ulcerative colitis

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON DEXTRAN;

ADOLESCENT; ADULT; AGED; ALLERGIC URTICARIA; ARTICLE; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HEMATOCRIT; HUMAN; IRON DEFICIENCY ANEMIA; MALE; MOLECULAR WEIGHT; NAUSEA; PRIORITY JOURNAL; PRURITUS; SINGLE DRUG DOSE; TACHYCARDIA; THORAX PAIN; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANEMIA, IRON-DEFICIENCY; COLITIS, ULCERATIVE; CROHN DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATINICS; HUMANS; IRON-DEXTRAN COMPLEX; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77954427833     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1022-y     Document Type: Article

References (31)

1. C Gasche MCE Lomer I Cavill G Weiss 2004 Iron, anaemia, and inflammatory bowel diseases Gut 53 1190 1197 10.1136/gut.2003.035758 1:CAS:528: DC%2BD2cXmvVehtbg%3D 15247190 (Pubitemid 38961976)
2. A Wilson E Reyes J Ofman 2004 Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature Am J Med 116 Suppl 7A 44S 49S 10.1016/j.amjmed.2003.12.011 15050885 (Pubitemid 38429899)
3. S Kulnigg C Gasche 2006 Systematic review: managing anaemia in Crohn's disease Aliment Pharmacol Ther 24 1507 1523 10.1111/j.1365-2036.2006.03146.x 1:CAS:528:DC%2BD2sXpslajuw%3D%3D 17206940 (Pubitemid 44915199)
4. G Tsiolakidou IE Koutroubakis 2007 Stimulating erythropoiesis in inflammatory bowel disease associated anemia World J Gastroenterol 13 4798 4806 1:CAS:528:DC%2BD2sXht1yit7fK 17828809 (Pubitemid 47496743)
5. C Gasche A Berstad R Befrits C Beglinger A Dignass K Erichsen et al. 2007 Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases Inflamm Bowel Dis 13 1545 1553 10.1002/ibd.20285 17985376
6. C Gasche T Waldhoer T Feichtenschlager C Male A Mayer C Mittermaier et al. 2001 Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia Am J Gastroenterol 96 2382 2387 1:CAS:528: DC%2BD3MXmsF2rt7c%3D 11513178 (Pubitemid 32769199)
7. G Bodemar S Kechagias S Almer BG Danielson 2004 Treatment of anaemia in inflammatory bowel disease with iron sucrose Scand J Gastroenterol 39 454 458 10.1080/00365520310008818-1 1:CAS:528:DC%2BD2cXjsVCqtLY%3D 15180183 (Pubitemid 38626625)
8. O Schröder O Mickisch U Seidler A de Weerth AU Dignass H Herfarth et al. 2005 Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study Am J Gastroenterol 100 2503 2509 10.1111/j.1572-0241.2005.00250.x 16279906 (Pubitemid 43919683)
9. K Erichsen RJ Ulvik G Nysaeter J Johansen J Ostborg A Berstad et al. 2005 Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease Scand J Gastroenterol 40 1058 1065 10.1080/00365520510023198 1:CAS:528:DC%2BD2MXhtVWitb%2FE 16165718 (Pubitemid 41291355)
10. IE Koutroubakis K Karmiris S Makreas C Xidakis M Niniraki EA Kouroumalis 2006 Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study Eur J Gastroenterol Hepatol 18 421 425 10.1097/00042737-200604000- 00017 1:CAS:528:DC%2BD28Xitlent7g%3D 16538115
11. CM Reddy SK Kathula SA Ali R Bekal M Walsh 2008 Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia Int J Clin Pract 62 413 415 10.1111/j.1742-1241.2007.01401.x 1:CAS:528:DC%2BC3cXksVKntb0%3D 18005041 (Pubitemid 351197408)
12. M Auerbach J Winchester A Wahab K Richards M McGinley F Hall et al. 1998 A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients Am J Kidney Dis 31 81 86 10.1053/ajkd.1998.v31. pm9428456 1:CAS:528:DyaK1cXkslartA%3D%3D 9428456 (Pubitemid 28116687)
13. S Anuradha NP Singh SK Agarwal 2002 Total dose infusion iron dextran therapy in predialysis chronic renal failure patients Ren Fail 24 307 313 10.1081/JDI-120005364 1:CAS:528:DC%2BD38XmsFagu7w%3D 12166697 (Pubitemid 34839951)
14. S Sinha DY Chiu G Peebles S Kolakkat E Lamerton S Fenwick et al. 2009 Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease J Ren Care 35 67 73 10.1111/j.1755-6686.2009.00099.x 19432851
15. S Bhandari S Naudeer 2008 Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice J Eval Clin Pract 14 996 1001 10.1111/j.1365-2753.2007.00932.x 18785894
16. R Ayub N Tariq MM Adil M Iqbal A Junaid T Jaferry 2008 Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy J Coll Physicians Surg Pak 18 424 427 18760066
17. P Mamula DA Piccoli SN Peck JE Markowitz RN Baldassano 2002 Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease J Pediatr Gastroenterol Nutr 34 286 290 10.1097/00005176-200203000-00011 1:CAS:528:DC%2BD38XktF2mu70%3D 11964953 (Pubitemid 34437521)
18. JE Lennard-Jones 1989 Classification of inflammatory bowel disease Scand J Gastroenterol Suppl 24 2 6 10.3109/00365528909091339
19. WR Best JM Becktel JW Singleton F Kern Jr 1976 Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study Gastroenterology 70 439 444 1:STN:280:DyaE287hvVGmtg%3D%3D 1248701
20. RS Walmsley RC Ayres RE Pounder RN Allan 1998 A simple clinical colitis activity index Gut 43 29 32 1:STN:280:DyaK1cvksVensw%3D%3D 9771402
21. AM Ganzoni 1970 Intravenous iron-dextran: therapeutic and experimental possibilities Schweiz Med Wochenschr 100 301 303 1:STN:280:DyaE3c7gvVKjtA%3D%3D 5413918
22. S Kulnigg S Stoinov V Simanenkov LV Dudar W Karnafel LC Garcia et al. 2008 A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial Am J Gastroenterol 103 1182 1192 10.1111/j.1572-0241.2007. 01744.x 1:CAS:528:DC%2BD1cXntFCrsrw%3D 18371137 (Pubitemid 351677967)
23. KA Lyseng-Williamson GM Keating 2009 Ferric carboxymaltose: a review of its use in iron-deficiency anaemia Drugs 69 739 756 10.2165/00003495-200969060- 00007 1:CAS:528:DC%2BD1MXnvFaitLg%3D 19405553
24. A Singh T Patel J Hertel M Bernardo A Kausz L Brenner 2008 Safety of ferumoxytol in patients with anemia and CKD Am J Kidney Dis 52 907 915 10.1053/j.ajkd.2008.08.001 1:CAS:528:DC%2BD1cXhsVarsbzO 18824288
25. GM Chertow PD Mason O Vaage-Nilsen J Ahlmén 2004 On the relative safety of parenteral iron formulations Nephrol Dial Transplant 19 1571 1575 10.1093/ndt/gfh185 1:CAS:528:DC%2BD2cXkt1Sqsrw%3D 15150356 (Pubitemid 38796422)
26. M Auerbach H Ballard J Glaspy 2007 Clinical update: intravenous iron for anaemia Lancet 369 1502 1504 10.1016/S0140-6736(07)60689-8 17482969 (Pubitemid 46670290)
27. A D'Arienzo F Manguso C Astarita FP D'Armiento R Scarpa D Gargano et al. 2000 Allergy and mucosal eosinophil infiltrate in ulcerative colitis Scand J Gastroenterol 35 624 631 10.1080/003655200750023598 10912663 (Pubitemid 30441714)
28. K Engkilde T Menné JD Johansen 2007 Inflammatory bowel disease in relation to contact allergy: a patient-based study Scand J Gastroenterol 42 572 576 10.1080/00365520600999334 17454877 (Pubitemid 46633805)
29. DA Blaustein MH Schwenk J Chattopadhyay H Singh R Daoui R Gadh et al. 2003 The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease Kidney Int Suppl 87 S72 S77 10.1046/j.1523-1755.64.s87.11.x 1:CAS:528:DC%2BD3sXpsVCrtLk%3D 14531777 (Pubitemid 37315511)
30. JM Hollands EF Foote A Rodriguez J Rothschild S Young 2006 Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease Am J Health Syst Pharm 63 731 734 10.2146/ajhp050173 1:CAS:528:DC%2BD28XksFSqtbY%3D 16595812
31. GC Wall RA Pauly 2008 Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia Am J Health Syst Pharm 65 150 153 10.2146/ajhp070222 1:CAS:528:DC%2BD1cXhvFGltbs%3D 18192261